IE
XENE icon

Israel Englander’s Xenon Pharmaceuticals XENE Stock Holding History

Israel Englander’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-45,000
Closed -$1.54M – 6615
2023
Q3 		$1.54M Buy
+45,000
New +$1.68M ﹤0.01% 3817
2021
Q4 		– Sell
-45,000
Closed -$688K – 7457
2021
Q3 		$688K Buy
+45,000
New +$782K ﹤0.01% 5040

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Israel Englander's XENE Position: Q2 2026 in Review

Israel Englander increased its Xenon Pharmaceuticals (XENE) stake by 87% in Q2 2026, buying an estimated $9.72M and bringing the position to 376,777 shares worth $22.7M. The position accounts for 0.01% of the portfolio, ranked #1515.

Israel Englander first reported a position in XENE in Q4 2016 and has held it in 31 quarters since. The position peaked at $55.6M in Q3 2025. 314 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Israel Englander held 376,777 shares of Xenon Pharmaceuticals worth $22.7M as of Q2 2026.
  • Israel Englander bought 174,992 Xenon Pharmaceuticals shares in Q2 2026, an estimated $9.72M.
  • Xenon Pharmaceuticals made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1515 holding.
  • Israel Englander first reported a position in Xenon Pharmaceuticals in Q4 2016 and has held it in 31 quarters since.
  • Israel Englander's Xenon Pharmaceuticals position peaked at $55.6M in Q3 2025.
  • 314 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.